Literature DB >> 11118448

ERK5 and ERK2 cooperate to regulate NF-kappaB and cell transformation.

G Pearson1, J M English, M A White, M H Cobb.   

Abstract

We have previously demonstrated an involvement of MEK5 and ERK5 in RafBXB-stimulated focus formation in NIH3T3 cells. We find here that MEK5 and ERK5 cooperate with the RafBXB effectors MEK1/2 and ERK1/2 to induce foci. To further understand MEK5-ERK5-dependent signaling, we examined potential MEK5-ERK5 effectors that might influence focus-forming activity. Consistent with results from our focus-formation assays, constitutively active variants of MEK5 and MEK1 synergize to activate NF-kappaB, and MEK5 and ERK5 are required for activation of NF-kappaB by RafBXB. The MEK5-ERK5 pathway is also sufficient to activate both NF-kappaB and p90 ribosomal S6 kinase. Our results support the hypothesis that NF-kappaB and p90 ribosomal S6 kinase are involved in MEK5-ERK5-dependent focus formation and may serve as integration points for ERK5 and ERK1/2 signaling.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11118448      PMCID: PMC4372717          DOI: 10.1074/jbc.M009764200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  Perspectives: signal transduction. Cell survival demands some Rsk.

Authors:  A R Nebreda; A C Gavin
Journal:  Science       Date:  1999-11-12       Impact factor: 47.728

2.  Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase.

Authors:  J Xing; D D Ginty; M E Greenberg
Journal:  Science       Date:  1996-08-16       Impact factor: 47.728

Review 3.  Signal transduction through MAP kinase cascades.

Authors:  T S Lewis; P S Shapiro; N G Ahn
Journal:  Adv Cancer Res       Date:  1998       Impact factor: 6.242

Review 4.  First- and second-generation antisense inhibitors targeted to human c-raf kinase: in vitro and in vivo studies.

Authors:  B P Monia
Journal:  Anticancer Drug Des       Date:  1997-07

Review 5.  Ras effectors and their role in mitogenesis and oncogenesis.

Authors:  T Joneson; D Bar-Sagi
Journal:  J Mol Med (Berl)       Date:  1997-08       Impact factor: 4.599

6.  IkappaB alpha is a target for the mitogen-activated 90 kDa ribosomal S6 kinase.

Authors:  G J Schouten; A C Vertegaal; S T Whiteside; A Israël; M Toebes; J C Dorsman; A J van der Eb; A Zantema
Journal:  EMBO J       Date:  1997-06-02       Impact factor: 11.598

7.  BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C.

Authors:  Y Kato; V V Kravchenko; R I Tapping; J Han; R J Ulevitch; J D Lee
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

Review 8.  Aberrant rel/nfkb genes and activity in human cancer.

Authors:  B Rayet; C Gélinas
Journal:  Oncogene       Date:  1999-11-22       Impact factor: 9.867

9.  Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor.

Authors:  Y Kato; R I Tapping; S Huang; M H Watson; R J Ulevitch; J D Lee
Journal:  Nature       Date:  1998-10-15       Impact factor: 49.962

10.  A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation.

Authors:  M J Robinson; S A Stippec; E Goldsmith; M A White; M H Cobb
Journal:  Curr Biol       Date:  1998-10-22       Impact factor: 10.834

View more
  34 in total

1.  Cell-cycle arrest by PD184352 requires inhibition of extracellular signal-regulated kinases (ERK) 1/2 but not ERK5/BMK1.

Authors:  Matthew S Squires; Paula M Nixon; Simon J Cook
Journal:  Biochem J       Date:  2002-09-01       Impact factor: 3.857

2.  Regulation of ERK5 by insulin and angiotensin-II in vascular smooth muscle cells.

Authors:  Girish Sharma; Marc Lee Goalstone
Journal:  Biochem Biophys Res Commun       Date:  2007-01-26       Impact factor: 3.575

3.  Targeted deletion of ERK5 MAP kinase in the developing nervous system impairs development of GABAergic interneurons in the main olfactory bulb and behavioral discrimination between structurally similar odorants.

Authors:  Junhui Zou; Yung-Wei Pan; Zhenshan Wang; Shih-Yu Chang; Wenbin Wang; Xin Wang; Cathy Tournier; Daniel R Storm; Zhengui Xia
Journal:  J Neurosci       Date:  2012-03-21       Impact factor: 6.167

4.  MAGI1 as a link between endothelial activation and ER stress drives atherosclerosis.

Authors:  Jun-Ichi Abe; Kyung Ae Ko; Sivareddy Kotla; Yin Wang; Jesus Paez-Mayorga; Ik Jae Shin; Masaki Imanishi; Hang Thi Vu; Yunting Tao; Miguel M Leiva-Juarez; Tamlyn N Thomas; Jan L Medina; Jong Hak Won; Yuka Fujii; Carolyn J Giancursio; Elena McBeath; Ji-Hyun Shin; Liliana Guzman; Rei J Abe; Jack Taunton; Naoki Mochizuki; William Faubion; John P Cooke; Keigi Fujiwara; Scott E Evans; Nhat-Tu Le
Journal:  JCI Insight       Date:  2019-04-04

5.  Poxviral regulation of the host NF-kappaB response: the vaccinia virus M2L protein inhibits induction of NF-kappaB activation via an ERK2 pathway in virus-infected human embryonic kidney cells.

Authors:  Roderick Gedey; Xiao-Lu Jin; Olivia Hinthong; Joanna L Shisler
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

6.  The C11R gene, which encodes the vaccinia virus growth factor, is partially responsible for MVA-induced NF-κB and ERK2 activation.

Authors:  Stefani Martin; Daniel T Harris; Joanna Shisler
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

Review 7.  Protein kinase C iota: human oncogene, prognostic marker and therapeutic target.

Authors:  Alan P Fields; Roderick P Regala
Journal:  Pharmacol Res       Date:  2007-05-05       Impact factor: 7.658

8.  Cyclic AMP selectively uncouples mitogen-activated protein kinase cascades from activating signals.

Authors:  Gray W Pearson; Svetlana Earnest; Melanie H Cobb
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

9.  Calcium regulation of EGF-induced ERK5 activation: role of Lad1-MEKK2 interaction.

Authors:  Zhong Yao; Seunghee Yoon; Eyal Kalie; Ziv Raviv; Rony Seger
Journal:  PLoS One       Date:  2010-09-07       Impact factor: 3.240

10.  miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice.

Authors:  Cyrielle Clapé; Vanessa Fritz; Corinne Henriquet; Florence Apparailly; Pedro Luis Fernandez; François Iborra; Christophe Avancès; Martin Villalba; Stéphane Culine; Lluis Fajas
Journal:  PLoS One       Date:  2009-10-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.